Soy protein and cardiovascular disease: The impact of bioactive components in soy

Nutrition Reviews

Volumn 56, Issue 8, 1998, Pages 231-235

  Potter, Susan M ^a,b  

^a Protein Technologies International   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GENISTEIN; ISOFLAVONE DERIVATIVE; SOYBEAN PROTEIN;

CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIETARY FIBER; DIETARY INTAKE; ENDOTHELIUM LESION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; REVIEW; THROMBOGENESIS;

EID: 0031679871     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1998.tb01754.x     Document Type: Review

References (43)

1. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82
2. Baum J, Teng HY, Erdman JW Jr, et al. Long-term intake of soy protein lowers the risk of cardiovascular disease and increases mononuclear cell LDL receptor mRNA in hypercholesterolemic postmenopausal women. Am J Clin Nutr (in press)
3. Fumagalli R, Soleri L, Farini R, et al. Fecal cholesterol excretion in type II hypercholesterolemic patients treated with soybean protein diet. Atherosclerosis 1982;43:341-53
4. Noseda G, Fragiacomo C, Descovich GC, et al. Clinical studies on the mechanism of action of the soybean protein diet. In: Fumagalli R, Kritchevsky D, Paoletti R, eds. Drugs affecting lipid metabolism. Amsterdam: Elsevier/North Holland Biochemical Press, 1980;355-62
5. Roda E, Mazella G, Cornia GL, et al. Effects of soybean protein-rich diet on biliary lipid composition. In: Barbara L, Miglioli M, Phillips SF, eds. New trends in pathophysiology and therapy of the large bowel. Amsterdam: Elsevier/North Holland Biochemical Press, 1983;309-12
6. Potter SM. Overview of possible mechanisms for the hypocholesterolemic effect of soy protein. J Nutr 1995;125:606S-11S
7. Potter SM. Soy protein and serum lipids. Curr Opin Lipidol 1996;7:260-4
8. Wong WW, Hachey DL, O'Brian Smith E, et al. Mechanisms for the hypocholesterolemic effect of soy protein in normocholesterolemic and hypercholesterolemic men. Proceedings of the Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, 1996;25
9. Khosla P, Samman S, Carroll KK. Decreased receptor-mediated LDL catabolism in casein-fed rabbits precedes the increase in plasma cholesterol levels. J Nutr Biochem 1991;2:203-9
10. Sirtori CR, Galli G, Lovati MR, et al. Effects of dietary proteins on the regulation of liver lipoprotein receptors in rats. J Nutr 1984;114:1493-1500
11. Lovati MR, Manzoni C, Canavesi A, et al. Soybean protein diet increases low-density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 1987;80: 1498-1502
12. Forsythe WA III. Comparison of dietary casein or soy protein effects on plasma lipids and hormone concentrations in the gerbil. J Nutr 1986;116:1165-71
13. Potter SM, Berber-Jimenez MD, Pertile J. Protein from soy concentrate and isolated soy protein alters blood lipids and hormones differently. J Nutr 1996;126:2007-11
14. Ham JO, Chapman KM, Essex-Sorlie D, et al. Endocrinological responses to soy protein and fiber in mildly hypercholesterolemic men. Nutr Res 1993;13:873-84
15. Balmir F, Potter SM, Essex-Sorlie D, et al. Endocrinological responses to soy protein and soy fiber in mildly hypercholesterolemic men (25 g study). FASEB J 1993;7:A802
16. Bakhit RM, Klein BP, Essex-Sorlie D, et al. Intake of 25 g soy protein reduces plasma cholesterol in men with elevated cholesterol concentrations. J Nutr 1994;124:213-22
17. Graham TL, Graham MY. Signaling in soybean phenylpropanoid responses: dissection of primary, secondary, and conditioning effects of light, wounding and elicitor treatments. Plant Physiol 1996;110:1123-33
18. Anthony MS, Clarkson TB, Hughes CL Jr, et al. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996;126:43-50
19. Huff MW, Carroll KK. Effects of dietary proteins and amino acid mixtures on plasma cholesterol levels in rabbits. J Nutr 1980;110:1676-85
20. Tasker T, Potter SM. Influence of dietary proteins and amino acid variation on plasma lipids, HMG CoA reductase activity, and reduced glutathione concentrations in inbred versus outbred gerbils. J Nutr Biochem 1993;4:458-62
21. Lovati MR, Manzoni C, Corsini A, et al. Low-density lipoprotein receptor activity is modulated by soybean globulins in cell culture. J Nutr 1992;122: 1971-8
22. Sugano M, Yamada Y, Yoshida K, et al. The hypocholesterolemic action of the undigested fraction of soybean protein in rats. Atherosclerosis 1988;72:115-22
23. Sugano M, Goto S, Tamada Y, et al. Cholesterol-lowering activity of various undigested fractions of soybean protein in rats. J Nutr 1990;120:977-85
24. Lo GS. Physiological effects of physico-chemical properties of soy cotyledon fiber. In: Gurda I, Brine CJ, eds. New developments in dietary fiber. New York: Plenum Press, 1990;49-66
25. Potter SM, Bakhit RM, Essex-Sorlie D, et al. Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am J Clin Nutr 1993;58:501-6
26. Carroll KK. Review of clinical studies on cholesterol-lowering response to soy protein. J Am Diet Assoc 1991;91:820-7
27. Shutt DA, Cox RI. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J Endocrinol 1972;52:299-310
28. Kuiper GGJM, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors and B. Endocrinology 1997;138:863-70
29. Huff MW, Roberts D, Carroll KK. Long-term effects of semipurified diets containing casein or soy protein isolate on atherosclerosis and plasma lipoproteins in rabbits. Atherosclerosis 1982;41:327-36
30. Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 1997;17:2524-31
31. Honoré EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997;67:148-54
32. Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251: 788-91
33. Ridker PM. Inflammation, infection, and cardiovascular risk: how is food the clinical evidence? Circulation 1998;97:1671-4
34. Entman ML, Ballantyne CM. Inflammation in acute coronary syndromes. Circulation 1993,88:800-3
35. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44
36. Ogawara H, Akiyama T, Watanabe S, et al. Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones. J Antibiotic 1989;42:340-3
37. Raines EW, Ross R. Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. J Nutr 1995;125(suppl):624-30
38. Wilcox JN, Blumenthal BF. Thrombic mechanisms in atherosclerosis: potential impact of soy proteins. J Nutr 1995;125(suppl):631-8
39. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimeno-pausal women. Arterioscler Thromb Vasc Biol 1997;17:3392-8
40. Greaves KA, Zhang LZ, Williams JK, et al. Phytoestrogens and intact soy protein administration differ in their effects on plasma lipids and lipoproteins. Proceedings of the Symposium on Phytoestrogen Research Methods, 1997
41. Crouse JR III, Terry JG, Morgan TM, et al. Soy protein containing isoflavones reduces plasma concentrations of lipids and lipoproteins. Circulation 1998;97:816
42. Sirtori CR, Gianazza E, Manzoni C, et al. Role of isoflavones in cholesterol reduction by soy proteins in the clinic. Am J Clin Nutr 1997;65:166-71
43. American Heart Association. 1998 heart and stroke statistical update. Dallas, TX: American Heart Association, 1997